慢性收缩性心力衰竭的药物治疗
摘要
心力衰竭(心衰)是一种复杂的临床症状群,是各种心脏病的严重阶段,其发病率高,5年存活率与恶性肿瘤相仿.已成为主要的公共卫生问题。对慢性心衰分阶段治疗的策略有利于防治慢性心衰的发生、发展,策略包括前心衰阶段(阶段A)、前临床心衰阶段(阶段B)、临床心衰阶段(阶段C)和难治性终末期心衰阶段(阶段D)。
出处
《岭南心血管病杂志》
2012年第3期208-209,229,共3页
South China Journal of Cardiovascular Diseases
参考文献5
-
1无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3677
-
2HUNT S A, ABRAHAM W T, CHIN M H, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation [ J 1. Circulation, 2009. 119(14) : e391- e479. 被引量:1
-
3DICKSTEIN K, COHEN-SOLAL A, FILIPPATOS G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) [J]. Eur Heart J, 2008, 29(19): 2388-2442. 被引量:1
-
4SWEDBERG K, KOMAJDA M, BOHM M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study [J]. Lancet, 2010, 376 (9744) : 875-885. 被引量:1
-
5CLELAND J G, COLETTA A P, BUGA L, et al. Clinical trials update from the American Heart Association meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND- HF, ROCKET-AF, and PROTECT [J]. Eur J Heart Fail, 2011, 13(4) : 460-465. 被引量:1
二级参考文献42
-
1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
-
2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L 被引量:1
-
3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23. 被引量:1
-
4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235. 被引量:1
-
5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140. 被引量:1
-
6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45. 被引量:1
-
7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2. 被引量:1
-
8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387. 被引量:1
-
9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274. 被引量:1
-
10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331. 被引量:1
共引文献3676
-
1范晓.蒙药沉香清心-8味散联合辛伐他汀治疗慢性心力衰竭的疗效及安全性分析[J].中国民族医药杂志,2023,29(3):1-3.
-
2李慧妍,霍经纬.沙库巴曲缬沙坦对慢性心力衰竭患者心功能及运动耐力的影响研究[J].智慧健康,2021,7(11):52-54. 被引量:6
-
3官雄忠.六经理论指导当归四逆汤联合美托洛尔治疗终末期心力衰竭的疗效[J].慢性病学杂志,2022(11):1743-1746.
-
4周玉能,黄昌宁,罗永盛.前列地尔和左西孟旦治疗失代偿性CHF患者的效果分析[J].慢性病学杂志,2022(8):1227-1229.
-
5肖景刚,孙百义,薛涛.阿托伐他汀对老年慢性心力衰竭患者炎性反应和心功能的影响[J].慢性病学杂志,2022(5):745-747. 被引量:1
-
6时非.慢性心力衰竭患者应用沙库巴曲缬沙坦治疗的临床疗效[J].慢性病学杂志,2020(11):1676-1677. 被引量:2
-
7栾海燕,李峥.综合个性化护理在脾肾阳虚型慢性充血性心力衰竭中西医治疗中的应用效果[J].慢性病学杂志,2020(8):1134-1138. 被引量:1
-
8杨燕,任海燕.个体化精细护理对慢性充血性心力衰竭手术患者心功能及心理应激状态的影响[J].慢性病学杂志,2020(5):728-729.
-
9吴晓铃.自我效能护理对老年慢性心力衰竭患者自我效能及心理状态的影响[J].慢性病学杂志,2020(4):586-587. 被引量:4
-
10王利红.磷酸肌酸钠联合依那普利对慢性心力衰竭患者心功能及血清NT-proBNP水平的影响[J].慢性病学杂志,2020,0(2):249-250. 被引量:4
-
1杨智,刘欣.螺内酯治疗充血性心力衰竭44例[J].陕西医学杂志,2008,37(8):1056-1057.
-
2朱文荣,何平,赵新龙.螺内酯治疗充血性心力衰竭效果观察[J].中国乡村医药,2007,14(11):12-12. 被引量:1
-
3李庆红,李燕燕,许根友.醛固酮拮抗剂治疗慢性心力衰竭的疗效分析[J].中国心血管病研究,2007,5(6):438-439. 被引量:2
-
4崔芳.螺内酯对急性心肌梗死心功能及节律的临床观察[J].中国误诊学杂志,2008,8(9):2045-2046.
-
5胡怡,刘立旻,张斌,高阳,熊盈,魏敏,毛宇强,陈松,陈思娇,宋今丹.醛固酮拮抗剂对代谢综合征合并慢性心力衰竭患者胰岛素抵抗指数和C-反应蛋白的影响[J].中国全科医学,2008,11(15):1332-1334. 被引量:10
-
6康小岗,杨和平.利尿剂、醛固酮拮抗剂及转化酶抑制剂联用治疗慢性充血性心力衰竭35例[J].陕西医学杂志,2005,34(10):1255-1255. 被引量:1
-
7李世云,李勤,李黎,甘莉,熊萍,饶进,杜春,李龙英,苟晓琴.螺内酯对2型糖尿病肾病患者尿清蛋白的影响[J].中国全科医学,2011,14(33):3784-3786. 被引量:9
-
8石焱,韩国珠.中西医结合分阶段治疗肺心病的体会[J].中医药研究,1993,9(2):41-42.
-
9史伟,唐爱华,吴金玉,张立军.中西医结合分阶段治疗狼疮性肾炎32例[J].现代中西医结合杂志,2000,9(19):1858-1860. 被引量:18
-
10侯惠芳,李琦.中药保留灌肠治疗溃疡性结肠炎68例[J].中医外治杂志,2002,11(2):26-26.